Ken Griffin Ptc Therapeutics, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $30,390 - $37,660	1,000 Added 21.28%	5,700 $211,000
Q2 2024 Aug 14, 2024	SELL	$24.69 - $40.12 $37,035 - $60,179	-1,500 Reduced 24.19%	4,700 $143,000
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $45,885 - $60,705	-1,900 Reduced 23.46%	6,200 $180,000
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $19,877 - $32,307	1,100 Added 15.71%	8,100 $223,000
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $6,723 - $12,597	-300 Reduced 4.11%	7,000 $156,000
Q2 2023 Aug 14, 2023	SELL	$40.4 - $59.1 $755,480 - $1.11 Million	-18,700 Reduced 71.92%	7,300 $296,000
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $896,759 - $1.15 Million	23,500 Added 940.0%	26,000 $1.26 Million
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $3.45 Million - $5.63 Million	-102,800 Reduced 97.63%	2,500 $95,000
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $849,555 - $1.09 Million	-20,300 Reduced 16.16%	105,300 $5.29 Million

222

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.14B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.